Albagli Zaliasnik SpA

IAM Research

The Patent 1000 focuses exclusively on patent practice and has firmly established itself as the definitive 'go-to' resource for those seeking world-class legal patent expertise.

Silver - Firms

Distinguished by its deep life sciences industry knowledge and facility for patent litigation, Albagli Zaliasnik provides essential support to pharmaceutical, biotechnology, food and beverage and agro-chemical companies as they navigate complex infringement issues and matters before the Chilean health and drug and competition authorities. Also adept at prosecution and cross-border transactions, the set offers a sophisticated, well-rounded service. Notable recent highlights include defending Abbott Laboratories in a battle with Bayer over two of the world’s most common oral contraceptives – Abbott’s Femelle and Bayer’s Yasmin. Joining forces to secure a crucial first-instance win for their client, Ariela Agosin, Daniel López and Eugenio Gormáz form the backbone of the patent practice. The group’s senior partner, Agosin capitalises on blended IP, competition and regulatory know-how and litigation experience to make the difference: “She is a quick study on technology and a practical, clear-sighted adviser.” López has similarly broad horizons, making him an asset to companies in any regulated industry; while his contributions as a member of litigation teams always add tremendous value. Well deserving of his promotion to the partnership in May 2020, IP group director Gormáz oversees filing activities and manages portfolios with acute attention to detail, and dispenses thoughtful strategic counsel to his many life sciences followers.

Get unlimited access to all IAM content